Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation
NCT02412579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2022-07-20
Summary
The purpose of this study is to determine whether genetic markers unique to liver cancer are present and to assess usefulness as a diagnostic tool.
Conditions
Interventions
- OTHER
-
None - Standard of Care
Sponsors & Collaborators
-
Baylor Research Institute
lead OTHER
Principal Investigators
-
Peter Kim, M.D. · Annette C. & Harold C. Simmons Transplant Institute
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2022-03-17
- Completion
- 2022-03-17
Countries
- United States
Study Locations
More Related Trials
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers
NCT06861621 ·Status: RECRUITING
-
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041 ·Status: RECRUITING ·Phase: NA
-
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)
NCT04025424 ·Status: UNKNOWN
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Comparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy Subjects
NCT03000621 ·Status: UNKNOWN
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910 ·Status: RECRUITING
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
NCT06759714 ·Status: RECRUITING
-
Treatment of Multifocal Lung Adenocarcinoma
NCT01946100 ·Status: TERMINATED ·Phase: NA
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Strategic Targeting for Optimal Prevention of Cancer
NCT03897374 ·Status: RECRUITING
-
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00858000 ·Status: COMPLETED
-
Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.
NCT03174574 ·Status: COMPLETED
-
Inherited CAncer REgistry
NCT03231891 ·Status: RECRUITING
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
NCT05901376 ·Status: UNKNOWN
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED